Schema-Root.org logo

 

  cross-referenced news and research resources about

 Myrtle Potter

Myrtle Potter

is President of Commercial Operations at Genentech. She leads Genentech's commercial operations, including Sales, Marketing, Managed Care, Business Development, Commercial Development, and Decision Support and Commercial Innovation functions. She also co-chairs Genentech's Product Portfolio Committee and is charged with providing strategic and financial oversight of the company's drug development portfolio. Prior to Genentech, Ms. Potter held prominent positions at Bristol-Meyers Squibb and Merck and Company.



In 2003, Ms. Potter was named to Fortune Magazine's Top 50 Most Powerful Women in Business, and in 2002 she was named to Fortune's Most Powerful Black Executives in America list. Also in 2002, Time Magazine named Ms. Potter to its list of 15 Young Global Business Influentials with especially promising and wide-reaching careers.

Myrtle Potter

is President of Commercial Operations at Genentech. She leads Genentech's commercial operations, including Sales, Marketing, Managed Care, Business Development, Commercial Development, and Decision Support and Commercial Innovation functions. She also co-chairs Genentech's Product Portfolio Committee and is charged with providing strategic and financial oversight of the company's drug development portfolio. Prior to Genentech, Ms. Potter held prominent positions at Bristol-Meyers Squibb and Merck and Company.

In 2003, Ms. Potter was named to Fortune Magazine's Top 50 Most Powerful Women in Business, and in 2002 she was named to Fortune's Most Powerful Black Executives in America list. Also in 2002, Time Magazine named Ms. Potter to its list of 15 Young Global Business Influentials with especially promising and wide-reaching careers.

Myrtle Potter

Myrtle Potter

images:  google   yahoo YouTube
spacer

updated Mon. April 16, 2018

-
... also Seekingalpha.com with their article: “An Analysis Of Axsome Therapeutics' Upcoming Catalysts” published on May 25, 2017, Globenewswire.com published: “Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors” on June 19, 2017. More interesting news about Axsome Therapeutics, ...
... Inc. (NASDAQ:AXSM) were released by: Globenewswire.com and their article: “Axsome Therapeutics Appoints John Golubieski as Chief Financial Officer” published on July 06, 2017 as well as Globenewswire.com's news article titled: “Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors” ...

More notable recent Axsome Therapeutics, Inc. (NASDAQ:AXSM) news were published by: Globenewswire.com which released: “Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors” on June 19, 2017, also Globenewswire.com with their article: “Axsome Therapeutics Announces AXS-06 ...
She was preceded in death by her beloved daughter Leigh Ann Pearson, parents and two older brothers, James M. Richardson, Jr. and John Warren Richardson as well as her father and mother-in-law Leroy A. Pearson and Myrtle Potter Pearson. Memorials may by be made to Ronald McDonald House, ...
More interesting news about Axsome Therapeutics, Inc. (NASDAQ:AXSM) were released by: Globenewswire.com and their article: “Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors” published on June 19, 2017 as well as Globenewswire.com's news article titled: “Axsome Therapeutics Reports First ...

Myrtle Potter was happy with her career as a health care corporate executive, having served as president and COO at Genentech, president at Bristol-Meyers Squibb and vice president at Merck. But her life took an unexpected turn one night in 2005 as she was resting in her family room. She started to ... Rite Aid
Steve Jobs has long been one of the wealthiest executives in the Bay Area. Last year, he became even richer. In 2003, Apple Computer paid the company co-founder and chief executive officer nearly $75 million, more than any other Bay Area executive, according to a study of 400 local, publicly ... Genentech
More interesting news about Axsome Therapeutics, Inc. (NASDAQ:AXSM) were released by: Globenewswire.com and their article: “Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors” published on June 19, 2017 as well as Seekingalpha.com's news article titled: “An Analysis Of Axsome ... Genentech
... Inc. (NASDAQ:AXSM) were released by: Globenewswire.com and their article: “Axsome Therapeutics Appoints John Golubieski as Chief Financial Officer” published on July 06, 2017 as well as Globenewswire.com's news article titled: “Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors” ... Genentech
She was preceded in death by her beloved daughter Leigh Ann Pearson, parents and two older brothers, James M. Richardson, Jr. and John Warren Richardson as well as her father and mother-in-law Leroy A. Pearson and Myrtle Potter Pearson. Memorials may by be made to Ronald McDonald House, ... Genentech
... 2017, Globenewswire.com published: “Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors” on June 19, 2017. More interesting news about Axsome Therapeutics, Inc. (NASDAQ:AXSM) were released by: Globenewswire.com and their article: “Axsome Therapeutics Announces AXS-02 ... Genentech
... Inc. (NASDAQ:AXSM) were released by: Globenewswire.com and their article: “Axsome Therapeutics Appoints John Golubieski as Chief Financial Officer” published on July 06, 2017 as well as Globenewswire.com's news article titled: “Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors” ... Genentech
... (NASDAQ:AXSM) were released by: Globenewswire.com and their article: “Axsome Therapeutics Announces AXS-07 for the Treatment of Migraine” published on November 28, 2017 as well as Globenewswire.com's news article titled: “Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors” ... Genentech
This activity has been headed largely by Myrtle Potter, a director of the company. Myrtle Potter has seen steady activity on the sell side, and on October 3, 2017, executed an option to sell 28189 shares. The disposition, at a price of $2.09, resulted in Myrtle Potter bringing total 78790 shares. Other officers ... Genentech
Myrtle Potter was happy with her career as a health care corporate executive, having served as president and COO at Genentech, president at Bristol-Meyers Squibb and vice president at Merck. But her life took an unexpected turn one night in 2005 as she was resting in her family room. She started to ... Genentech
Steve Jobs has long been one of the wealthiest executives in the Bay Area. Last year, he became even richer. In 2003, Apple Computer paid the company co-founder and chief executive officer nearly $75 million, more than any other Bay Area executive, according to a study of 400 local, publicly traded ... Genentech

Steve Jobs has long been one of the wealthiest executives in the Bay Area. Last year, he became even richer. In 2003, Apple Computer paid the company co-founder and chief executive officer nearly $75 million, more than any other Bay Area executive, according to a study of 400 local, publicly traded ... Genentech
More notable recent Axsome Therapeutics, Inc. (NASDAQ:AXSM) news were published by: Globenewswire.com which released: “Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors” on June 19, 2017, also Globenewswire.com with their article: “Axsome Therapeutics Announces AXS-06 ... Genentech
Myrtle Potter, a former pharmaceutical executive who has known Frazier for about 15 years, said he has the ability to foster the kind of innovation the industry needs to sustain itself. Potter now runs a healthcare advisory firm, Myrtle Potter & Company in the Silicon Valley. "He has the strategic breadth and ... Genentech
This activity has been headed largely by Myrtle Potter, a director of the company. Myrtle Potter has seen steady activity on the sell side, and on ... Genentech
This activity has been headed largely by Myrtle Potter, a director of the company. Myrtle Potter has seen steady activity on the sell side, and on ... Genentech
A native and lifelong resident of McMinn County, he was a son of the late Charlie and Myrtle Potter Johnson, and was also preceded in death ... Genentech
Myrtle Potter was happy with her career as a health care corporate executive, having served as president and COO at Genentech, president at ... Genentech
Myrtle Potter was happy with her career as a health care corporate executive, having served as president and COO at Genentech, president at ... Genentech
Steve Jobs has long been one of the wealthiest executives in the Bay Area. Last year, he became even richer. In 2003, Apple Computer paid ... Genentech
He has to be an internal and external cheerleader and a magnet for talent.'' Myrtle Potter, a former pharmaceutical executive who has known ... Genentech
... Therapeutics Inc (NASDAQ:AXSM) were released by: Reuters.com and their article: “BRIEF-Axsome Therapeutics appoints Myrtle Potter as a ... Genentech
Myrtle Potter – Prior experience. After starting her career with Procter and Gamble Patient Care Products, Ms. Potter went on to spend 14 years ... Genentech
Myrtle Potter – Prior experience. After starting her career with Procter and Gamble Patient Care Products, Ms. Potter went on to spend 14 years ... Genentech
A native and lifelong resident of McMinn County, he was a son of the late Charlie and Myrtle Potter Johnson, and was also preceded in death ... Genentech
Myrtle Potter – Prior experience. After starting her career with Procter and Gamble Patient Care Products, Ms. Potter went on to spend 14 years ... Genentech
As of late, it has definitely been a great time to be an investor in Axsome Therapeutics Inc (AXSM - Free Report) . The stock has moved higher ... Genentech
Potter is the Chief Executive Officer and Founder of Myrtle Potter & Company, a healthcare and life science advisory firm. She previously served ... Genentech
Myrtle Potter was happy with her career as a health care corporate executive, having served as president and COO at Genentech, president at ... Genentech
18 in U.S. District Court for the Southern District of New York against Everyday Health Inc., Doug McCormick, Ben Wolin, Habi B. Kairouz, David Golden, Sharon Wienbar, Myrtle Potter, Dan Evan and Laizer Kornwasser, alleging violation of the 1934 SEC ... Genentech
The director of Insmed Inc, Myrtle Potter has made a sudden trade in the Pinksheet-listed company that is with a grand total value of $82,731 US Dollars. Genentech
/s/ Myrtle Potter, by Christine Pellizzari as Attorney-in-fact, 12/15/2016. ** Signature of Reporting Person, Date. Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Genentech
The director of Insmed Inc, Myrtle Potter has made a sudden trade in the Pinksheet-listed company that is with a grand total value of $82,731 US Dollars. Genentech


 

news and opinion


 


 


 


 


schema-root.org

  career
   business
     myrtle potter

business people:
     advisors
     alex vanselow
     alfred sirven
     allan m. holt
     amelia fawcett
     amy domini
     andrea jung
     anne mulcahy
     arms merchants
     arthur levitt
     bankers
     bernard ebbers
     bill gates
     bob j. perry
     brokers
     capitalists
     charles koch
     christina gold
     christine poon
     clara furse
     conrad black
     consultants
     contractors
     craig newmark
     david lesar
     david o'reilly
     dawn hudson
     donald trump
     eleana benador
     ely calil
     entrepreneurs
     financiers
     fund managers
     gail berman
     gary cohen
     gary winnick
     gene w. ray
     george david
     george soros
     george yates
     haim saban
     howard hughes
     investors
     jack valenti
     james mulva
     jamie dimon
     jenny ming
     john rigas
     john sperling
     kate swann
     kathleen cox
     ken lay
     kenneth lerer
     larry flint
     lee raymond
     lester crown
     linda dillman
     lobbyists
     lois quam
     louis boccardi
     managers
     marc rich
     marc weisberg
     mark thatcher
     mary sammons
     maurice strong
     meg whitman
     mercenaries
     michael dell
     michael gross
     mitchell wade
     myrtle potter
     publicists
     publishers
     pug winokur
     ray lee hunt
     realtors
     richard cohen
     roger ailes
     roland betts
     ronald sugar
     ross pillari
     rupert murdoch
     scott richter
     scott sullivan
     sly bailey
     steve jobs
     ted turner
     tim ryan
     timothy rigas
     tycoons
     ursula burns
     val gooding
     vivienne cox
     warren buffet
     william conway
     william franke